Evidence map›Paper›PMID 41216092›Full record

ArticleCureus2025

Melorheostosis of the Hip: A Case Report.

Shuichi Fujiwara, Ikuo Fujita, Toshiyuki Takemori, Takuya Fujimoto, Shunsuke Yahiro, Ami Sawada, Ryosuke Kuroda

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuichi FujiwaraDepartment of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, JPN.
Ikuo FujitaDepartment of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, JPN.
Toshiyuki TakemoriDepartment of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, JPN.
Takuya FujimotoDepartment of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, JPN.
Shunsuke YahiroDepartment of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, JPN.
Ami SawadaDepartment of Orthopaedic Surgery, Hyogo Cancer Center, Akashi, JPN.
Ryosuke KurodaDepartment of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melorheostosis, also known as Leri's disease, is a rare sclerosing bone dysplasia characterized by abnormal overgrowth of cortical bone, typically appearing as "dripping candle wax" on imaging. It most commonly affects the diaphyseal regions of the long bones in the lower limbs and may result in limb-length discrepancy, joint stiffness, progressive deformity, and soft tissue ossification. Owing to its rarity, treatment approaches are usually individualized. Here, we report the case of a 41-year-old female who presented with progressive limitation of right hip mobility since childhood, which began to interfere with daily activities. Imaging revealed extensive soft tissue ossification and endomedullary sclerosis around the right hip with cortical excrescence resembling candle wax dripping, suggesting melorheostosis. Following multidisciplinary evaluation, surgical excision of the bony mass and passive manipulation of the hip joint were performed. Histological examination confirmed a dense, compact bone resembling cortical bone. Postoperatively, hip flexion improved from 20° to 60° and abduction improved from 15° to 20°, with no evidence of joint instability. At the 30-month follow-up, mild limitation of motion persisted (flexion, 45°; abduction, 25°); however, the patient maintained good function with no significant impact on daily activities.

Indexed as

hyperostosisleri’s diseasemanipulationmelorheostosissurgical intervention

Identifiers

PMID41216092
PMCPMC12597106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.